Patent details

EP2136633 Title: ONCOLYTIC VACCINIA VIRUS CANCER THERAPY

Basic Information

Publication number:
EP2136633
PCT Application Number:
PCT/US/2008/057257
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP087323580
PCT Publication Number:
WO/2008/113078
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
ONCOLYTIC VACCINIA VIRUS CANCER THERAPY
French Title of Invention:
TRAITEMENT DU CANCER AVEC LE VIRUS DE LA VACCINE ONCOLYTIQUE
German Title of Invention:
KREBSTHERAPIE MIT ONKOLYTISCHEM VACCINIAVIRUS
SPC Number:

Dates

Filing date:
17/03/2008
Grant date:
28/10/2015
EP Publication Date:
28/10/2015
PCT Publication Date:
18/09/2008
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
30/12/2009
EP B1 Publication Date:
28/10/2015
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
17/03/2020
Expiration date:
17/03/2028
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
17/03/2008
 
 

Name:
SillaJen Biotherapeutics Inc.
Address:
450 Sansome Street, Suite 650, San Francisco, CA 94111, United States (US)

Inventor

Name:
KIRN David
Address:
United States (US)

Priority

Priority Number:
894932 P
Priority Date:
15/03/2007
Priority Country:
United States (US)

Classification

Main IPC Class:
A01N 43/04;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
27/03/2019
Last Annual Fee Paid Number:
12
Last Annual Fee Paid Amount:
165 Euro
Payer:
Computer Packages INC
Filing date Document type Number of pages